Evidence map›Paper›PMID 23357829›Full record

ReviewPrion

A microbial sensor for discovering structural probes of protein misfolding and aggregation.

Dujduan Waraho-Zhmayev, Lizeta Gkogka, Ta-Yi Yu, Matthew P DeLisa

Abstract readReview
In one paragraph

Review in Prion. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Directed evolution to improve protein folding in vivo.Current opinion in structural biology · 2018
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dujduan Waraho-ZhmayevSchool of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY USA.
Lizeta Gkogka
Ta-Yi Yu
Matthew P DeLisa

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In all cell types, protein homeostasis, or "proteostasis," is maintained by sophisticated quality control networks that regulate protein synthesis, folding, trafficking, aggregation, disaggregation, and degradation. In one notable example, Escherichia coli employ a proteostasis system that determines whether substrates of the twin-arginine translocation (Tat) pathway are correctly folded and thus suitable for transport across the tightly sealed cytoplasmic membrane. Herein, we review growing evidence that the Tat translocase itself discriminates folded proteins from those that are misfolded and/or aggregated, preferentially exporting only the former. Genetic suppressors that inactivate this mechanism have recently been isolated and provide direct evidence for the participation of the Tat translocase in structural proofreading of its protein substrates. We also discuss how this discriminatory "folding sensor" has been exploited for the discovery of structural probes (e.g., sequence mutations, pharmacologic chaperones, intracellular antibodies) that modulate the folding and solubility of virtually any protein-of-interest, including those associated with aggregation diseases (e.g., α-synuclein, amyloid-β protein). Taken together, these studies highlight the utility of engineered bacteria for rapidly and inexpensively uncovering potent anti-aggregation factors.

Indexed as

AmyloidAntibodiesBiosensing TechniquesBiotechnologyEscherichia coliEscherichia coli ProteinsHigh-Throughput Screening AssaysIntracellular SpaceMembrane Transport ProteinsModels, MolecularMolecular Probe TechniquesProtein BindingProtein FoldingAmyloidAntibodiesEscherichia coli ProteinsMembrane Transport Proteinstwin-arginine translocase complex, E coliaggregationamyloid-β proteinantibody therapieschemical chaperonesdirected evolutionfolding quality controlhigh-throughput screeningprotein misfolding disordersprotein secretionα-synuclein

Identifiers

PMID23357829
PMCPMC3609123

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.